Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia

Clinical trial NCT02240173 · UNKNOWN

Trial details

NCT number: NCT02240173
Sponsor: Federal Neuro-Psychiatric Hospital, Yaba
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Schizophrenia and Disorders With Psychotic Features

Start date: 2017-06-01
Primary completion: 2017-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.